IMV Inc. to Present at the H.C. Wainwright 20th Annual Global Investment Conference
August 23 2018 - 7:05AM
IMV Inc. (Nasdaq: IMV; TSX: IMV), a clinical stage immuno-oncology
corporation, today announced that Chief Executive Officer Frederic
Ors and Chief Financial Officer Pierre Labbé will present a
corporate update at the H.C. Wainwright 20th Annual Global
Investment Conference, which takes place September 5 – 6, 2018, in
New York, NY.
IMV’s presentation details include:
- Date: Thursday, September 6, 2018
- Time: 12:05 – 12:30 p.m. ET
- Location: The Library (Second Floor), The St.
Regis Hotel
There will be a live webcast of IMV’s presentation accessible
via the following URL: http://wsw.com/webcast/rrshq28/imv/. The
webcast will be archived for 90 days following the live
presentation. A copy of the presentation will be available on the
Events & Presentations page of IMV’s website:
www.imv-inc.com.
About IMV
IMV Inc., formerly Immunovaccine Inc., is a clinical stage
biopharmaceutical company dedicated to making immunotherapy more
effective, more broadly applicable, and more widely available to
people facing cancer and other serious diseases. IMV is pioneering
a new class of immunotherapies based on the Company’s proprietary
drug delivery platform. This patented technology leverages a novel
mechanism of action that enables the programming of immune cells in
vivo, which are aimed at generating powerful new synthetic
therapeutic capabilities. IMV’s lead candidate, DPX-Survivac, is a
T cell-activating immunotherapy that combines the utility of the
platform with a target: survivin. IMV is currently assessing
DPX-Survivac as a combination therapy in multiple clinical studies
with Incyte and Merck. Connect at www.imv-inc.com.
Contacts for
IMV:MEDIA Mike Beyer, Sam
Brown Inc.T: (312) 961-2502 E: mikebeyer@sambrown.com
INVESTOR RELATIONSPierre Labbé, Chief
Financial OfficerT: (902) 492-1819 E:
info@imv-inc.com
Patti Bank, Managing Director, Westwicke
PartnersO: (415) 513-1284T: (415) 515-4572 E:
patti.bank@westwicke.com
IMV (TSX:IMV)
Historical Stock Chart
From Jun 2024 to Jul 2024
IMV (TSX:IMV)
Historical Stock Chart
From Jul 2023 to Jul 2024